NASDAQ:CRIS

Curis Stock Predictions

Healthcare > Biotechnology

Buy CRIS

*Your capital is at risk

$0.500

-0.0025 (-0.498%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CRIS Prediction Chart

CRIS Predictions History

Latest community submissions for CRIS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Apr 24, 2017	$2.54 -99.00%	$2.55	X	99.60%	4
Ryan.Ellis.6050	Apr 24, 2017	$2.70 -98.94%	$2.55	X	94.10%	0
JS Pro	Apr 18, 2017	$2.66 -98.99%	$2.63	X	98.90%	1
JS Pro	Dec 21, 2016	$3.50 -98.96%	$3.36	X	95.80%	0
John.Salery.1158	Oct 11, 2016	$3.33 -98.89%	$3.01	V	89.40%	0
JS Pro	Oct 6, 2016	$3.20 -98.94%	$3.02	X	94.00%	0
Alvaro.Lopez.979	Sep 19, 2016	$2.12 -99.00%	$2.11	X	99.50%	4
Bryce.Nurding.231	Jun 3, 2016	$2.12 -98.87%	$1.87	X	86.60%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRIS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CURIS

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by